Mainz Biomed MYNZ Stock
Mainz Biomed Price Chart
Mainz Biomed MYNZ Financial and Trading Overview
| Mainz Biomed stock price | 0.84 USD |
| Previous Close | 0.82 USD |
| Open | 0.8 USD |
| Bid | 0.78 USD x 100 |
| Ask | 0.79 USD x 100 |
| Day's Range | 0.74 - 0.86 USD |
| 52 Week Range | 0.55 - 5.34 USD |
| Volume | 5.24M USD |
| Avg. Volume | 625.47K USD |
| Market Cap | 10.56M USD |
| Beta (5Y Monthly) | 0.317 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MYNZ Valuation Measures
| Enterprise Value | 4.29M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.1406757 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 16.007933 |
| Price/Book (mrq) | 1.3702922 |
| Enterprise Value/Revenue | 6.494 |
| Enterprise Value/EBITDA | -0.265 |
Trading Information
Mainz Biomed Stock Price History
| Beta (5Y Monthly) | 0.317 |
| 52-Week Change | -87.53% |
| S&P500 52-Week Change | 25.59% |
| 52 Week High | 5.34 USD |
| 52 Week Low | 0.55 USD |
| 50-Day Moving Average | 0.92 USD |
| 200-Day Moving Average | 1.35 USD |
MYNZ Share Statistics
| Avg. Volume (3 month) | 625.47K USD |
| Avg. Daily Volume (10-Days) | 1.1M USD |
| Shares Outstanding | 12.52M |
| Float | 3.46M |
| Short Ratio | 0.82 |
| % Held by Insiders | 17.43% |
| % Held by Institutions | 13.05% |
| Shares Short | 467.58K |
| Short % of Float | 3.75% |
| Short % of Shares Outstanding | 3.74% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | June 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2822.059% |
| Gross Margin | 67.49% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -114.35% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 659.94K USD |
| Revenue Per Share (ttm) | 0.29 USD |
| Quarterly Revenue Growth (yoy) | -44.89% |
| Gross Profit (ttm) | 445.43K USD |
| EBITDA | -16145343 USD |
| Net Income Avi to Common (ttm) | -18971112 USD |
| Diluted EPS (ttm) | -5.28 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.91M USD |
| Total Cash Per Share (mrq) | 0.47 USD |
| Total Debt (mrq) | 3.09M USD |
| Total Debt/Equity (mrq) | 122.65 USD |
| Current Ratio (mrq) | 0.515 |
| Book Value Per Share (mrq) | 0.616 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15461421 USD |
| Levered Free Cash Flow (ttm) | -8186486 USD |
Profile of Mainz Biomed
| Country | United States |
| State | N/A |
| City | Mainz |
| Address | Robert Koch Strasse 50 |
| ZIP | 55129 |
| Phone | 49 6131 554 2860 |
| Website | https://mainzbiomed.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 19 |
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.
Q&A For Mainz Biomed Stock
What is a current MYNZ stock price?
Mainz Biomed MYNZ stock price today per share is 0.84 USD.
How to purchase Mainz Biomed stock?
You can buy MYNZ shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mainz Biomed?
The stock symbol or ticker of Mainz Biomed is MYNZ.
Which industry does the Mainz Biomed company belong to?
The Mainz Biomed industry is Diagnostics & Research.
How many shares does Mainz Biomed have in circulation?
The max supply of Mainz Biomed shares is 12.52M.
What is Mainz Biomed Price to Earnings Ratio (PE Ratio)?
Mainz Biomed PE Ratio is 0.00000000 now.
What was Mainz Biomed earnings per share over the trailing 12 months (TTM)?
Mainz Biomed EPS is 0 USD over the trailing 12 months.
Which sector does the Mainz Biomed company belong to?
The Mainz Biomed sector is Healthcare.
Mainz Biomed MYNZ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}